| Objective | Smoking cessation | Healthy diet and physical activity | Lipid lowering | Hypertension treatment | Diabetes treatments | Antiplatelet therapy | Arterial reconstruction |
---|---|---|---|---|---|---|---|---|
ACCF AHA | Management of PAD | Recommended | Â | Recommended | Recommended; ACEi may be considered | Recommended | Asymptomatic LEAD: Indicated; Asymptomatic PAD with ABI (0.91-0.99): Usefulness is not well established | Not indicated as prophylactic therapy |
ACCP | Antithrombotic Therapy in PAD | Â | Â | Â | Â | Â | Asymptomatic PAD: Aspirin 75 to 100 mg daily | Â |
AHA ACC | Management of LEAD |  |  |  |  |  | Asymptomatic PAD (ABI≤0.90): Reasonable; Asymptomatic PAD with ABI (0.91-0.99): Uncertain |  |
BWG | Diagnosis and treatment of PAD | Recommended |  | Stains: LDL-C< 100 mgdl If high risk, LDL-C < 70 mgdl | BP<140/90 mmHg; BP <130/80 mmHg if diabetes renal insufficiency | HbA1c < 7%, as low as possible | All PAD patients: ASA (75-150 mg) ASA is contra-indicated new CV event under ASA treatment: Clopidogrel (Plavix® 75 mg) |  |
CEVF | Management of IC | Recommended | Â | Recommended | Recommended | Recommended | Asymptomatic LEAD: Indicated | Â |
ESC | Diagnosis and treatment of PAD | Recommended | Recommended | Stains LDL-C <70mgdL; If initial LDL-C level is 70-135mgdL, decreased by >50% | Recommended | Recommended | Not routinely indicated in isolated asymptomatic LEAD | Â |
GSA | Diagnosis and treatment of PAOD | Â | Â | Â | Â | Â | Â | Not indicated for Asymptom-atic PAOD |
ISD | Treatment of PAD in diabetes | Â | Â | Â | Â | Â | Diabetic + aged >50 years+ asymptomatic PAD: Long-term daily aspirin (75-100 mg) | Â |
KSIR | Interventional Recanalization of Lower Extremity Arteries | Â | Â | Â | Â | Â | Â | Not require prophylactic Recanalization |
SVS | Management of asymptomatic atherosclerotic occlusive disease of the lower extremities and claudication | Recommended (repeatedly until tobacco use has stopped) | Â | Â | Â | Â | Â | Against invasive treatments for PAD in the absence of symptoms |
TASC | Management of PAD | Â | Â | LDL-C <100mgdl | Â | Â | Â | Â |